FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084865214> ?p ?o ?g. }

• W2084865214 abstract "Drug-mediated thrombotic microangiopathy may cause life-threatening medical emergencies. Novel targeted therapies have dramatically changed the prognosis of a number of oncological diseases. Tyrosine kinase inhibitors of the Breakpoint Cluster Region-Abelson (BCR-ABL) oncoprotein are used in patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. Imatinib mesylate, which was the first anti-BCR-ABL tyrosine kinase inhibitor, has demonstrated a high tolerance profile and efficacy in these patients for many years. Good results have also been observed in patients with gastrointestinal stromal tumors. In this study, we describe two patients with Philadelphia chromosome-positive hematological malignancies who presented with secondary thrombotic microangiopathy that was most likely linked to the use of imatinib. Other potential causes of thrombotic microangiopathy were discarded, and the predisposing role of some comorbidities and potential short or long-term drug–drug interactions was assessed. The clinical and biological data were more indicative of atypical secondary hemolytic uremic syndrome in one of the cases and of secondary thrombotic microangiopathy with renal and cardiac impairment in the other, which is also categorized as secondary hemolytic uremic syndrome. The outcome was favorable after imatinib discontinuation and the treatment of severe cardiac and renal failures." @default.
• W2084865214 created "2016-06-24" @default.
• W2084865214 creator A5023008376 @default.
• W2084865214 creator A5037817902 @default.
• W2084865214 creator A5038195700 @default.
• W2084865214 creator A5045464722 @default.
• W2084865214 creator A5056820389 @default.
• W2084865214 creator A5058658059 @default.
• W2084865214 creator A5068800702 @default.
• W2084865214 creator A5074111440 @default.
• W2084865214 creator A5079604805 @default.
• W2084865214 creator A5082195804 @default.
• W2084865214 date "2015-01-14" @default.
• W2084865214 modified "2023-10-17" @default.
• W2084865214 title "Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate" @default.
• W2084865214 cites W1966431174 @default.
• W2084865214 cites W1972678915 @default.
• W2084865214 cites W1977528952 @default.
• W2084865214 cites W1977996924 @default.
• W2084865214 cites W1980805976 @default.
• W2084865214 cites W1982003857 @default.
• W2084865214 cites W1983118965 @default.
• W2084865214 cites W1987045819 @default.
• W2084865214 cites W1997059216 @default.
• W2084865214 cites W1997285777 @default.
• W2084865214 cites W1998990808 @default.
• W2084865214 cites W2000116184 @default.
• W2084865214 cites W2001335864 @default.
• W2084865214 cites W2005282952 @default.
• W2084865214 cites W2013420991 @default.
• W2084865214 cites W2014185280 @default.
• W2084865214 cites W2034696019 @default.
• W2084865214 cites W2038181025 @default.
• W2084865214 cites W2038432760 @default.
• W2084865214 cites W2039724947 @default.
• W2084865214 cites W2039898149 @default.
• W2084865214 cites W2042290667 @default.
• W2084865214 cites W2046963455 @default.
• W2084865214 cites W2048984662 @default.
• W2084865214 cites W2051061320 @default.
• W2084865214 cites W2051566553 @default.
• W2084865214 cites W2067978628 @default.
• W2084865214 cites W2068248632 @default.
• W2084865214 cites W2078450039 @default.
• W2084865214 cites W2091558248 @default.
• W2084865214 cites W2094918682 @default.
• W2084865214 cites W2098435910 @default.
• W2084865214 cites W2107268345 @default.
• W2084865214 cites W2114604545 @default.
• W2084865214 cites W2116168245 @default.
• W2084865214 cites W2117356576 @default.
• W2084865214 cites W2125194720 @default.
• W2084865214 cites W2125829506 @default.
• W2084865214 cites W2127445947 @default.
• W2084865214 cites W2146658232 @default.
• W2084865214 cites W2147109509 @default.
• W2084865214 cites W2158943356 @default.
• W2084865214 cites W2166674619 @default.
• W2084865214 cites W2979830181 @default.
• W2084865214 cites W4238378618 @default.
• W2084865214 doi "https://doi.org/10.1177/1078155214568580" @default.
• W2084865214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25591869" @default.
• W2084865214 hasPublicationYear "2015" @default.
• W2084865214 type Work @default.
• W2084865214 sameAs 2084865214 @default.
• W2084865214 citedByCount "10" @default.
• W2084865214 countsByYear W20848652142016 @default.
• W2084865214 countsByYear W20848652142018 @default.
• W2084865214 countsByYear W20848652142019 @default.
• W2084865214 countsByYear W20848652142020 @default.
• W2084865214 countsByYear W20848652142021 @default.
• W2084865214 countsByYear W20848652142022 @default.
• W2084865214 crossrefType "journal-article" @default.
• W2084865214 hasAuthorship W2084865214A5023008376 @default.
• W2084865214 hasAuthorship W2084865214A5037817902 @default.
• W2084865214 hasAuthorship W2084865214A5038195700 @default.
• W2084865214 hasAuthorship W2084865214A5045464722 @default.
• W2084865214 hasAuthorship W2084865214A5056820389 @default.
• W2084865214 hasAuthorship W2084865214A5058658059 @default.
• W2084865214 hasAuthorship W2084865214A5068800702 @default.
• W2084865214 hasAuthorship W2084865214A5074111440 @default.
• W2084865214 hasAuthorship W2084865214A5079604805 @default.
• W2084865214 hasAuthorship W2084865214A5082195804 @default.
• W2084865214 hasConcept C104317684 @default.
• W2084865214 hasConcept C121608353 @default.
• W2084865214 hasConcept C126322002 @default.
• W2084865214 hasConcept C138626823 @default.
• W2084865214 hasConcept C170493617 @default.
• W2084865214 hasConcept C185592680 @default.
• W2084865214 hasConcept C2777583451 @default.
• W2084865214 hasConcept C2777878052 @default.
• W2084865214 hasConcept C2778715236 @default.
• W2084865214 hasConcept C2778729363 @default.
• W2084865214 hasConcept C2778820342 @default.
• W2084865214 hasConcept C2778904597 @default.
• W2084865214 hasConcept C2779134260 @default.
• W2084865214 hasConcept C3019892230 @default.
• W2084865214 hasConcept C42362537 @default.
• W2084865214 hasConcept C55493867 @default.
• W2084865214 hasConcept C71924100 @default.

• next